Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]

El Hindi T.Anugulruengkitt S.Lapphra K.Limkittikul K.Tangsathapornpong A.Galindo C.M.Hellwig M.Roubinis N.Schuring R.Biswal S.Folschweiller N.Mahidol University2025-10-172025-10-172025-01-01Vaccine (2025)0264410Xhttps://repository.li.mahidol.ac.th/handle/123456789/112626Biochemistry, Genetics and Molecular BiologyMedicineImmunology and MicrobiologyVeterinaryCorrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]ErratumSCOPUS10.1016/j.vaccine.2025.1277852-s2.0-10501805083918732518